Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomunil/Immucytal for prevention of recurrent respiratory infections in socialized children
2008-000487-17Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bacterial ribosomal and membrane fractions in upper respiratory infection (URI) and Airways Infection (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Overall duration of infective episodes. Started Apr 2008; status: completed.
02
Drugs
bacterial ribosomal and membrane fractions
03
Conditions
upper respiratory infection (URI)Airways Infection
Beyond the preview
Go deeper on 2008-000487-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000487-17.